DBCG-IMN: A population-based cohort study on the effect of internal mammary node irradiation in early node-positive breast cancer

Journal of Clinical Oncology

Volumn 34, Issue 4, 2016, Pages 314-320

  Thorsen, Lise Bech Jellesmark ^a   Offersen, Birgitte Vrou ^a   Danø, Hella ^b   Berg, Martin ^c   Jensen, Ingelise ^d   Pedersen, Anders Navrsted ^e   Zimmermann, Sune Jürg ^f   Brodersen, Hans Jürgen ^g   Overgaard, Marie ^a   Overgaard, Jens ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c LILLEBAELT HOSPITAL   (Denmark)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

^e University of Copenhagen   (Denmark)

^f ODENSE UNIVERSITY HOSPITAL   (Denmark)

^g St Franziskus Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT RADIOTHERAPY; ADULT; BREAST NEOPLASMS; COHORT ANALYSIS; DENMARK; EPIDEMIOLOGY; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROSPECTIVE STUDY; RADIATION RESPONSE;

ADULT; BREAST NEOPLASMS; COHORT STUDIES; DENMARK; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT;

EID: 84955490095     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.63.6456     Document Type: Article

References (31)

1. Overgaard M, Hansen PS, Overgaard J, et al: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy: Danish Breast Cancer Cooperative Group 82b trial. N Engl J Med 337:949-955, 1997
2. Overgaard M, Jensen MB, Overgaard J, et al: Postoperative radiotherapy in high-risk post-menopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353:1641-1648, 1999
3. Ragaz J, Jackson SM, Le N, et al: Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337:956-962, 1997
4. Clarke M, Collins R, Darby S, et al: Early Breast Cancer Trialists' Collaborative Group(EBCTCG): Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 366:2087-2106, 2005
5. McGale P, Taylor C, Correa C, et al: EBCTCG (Early Breast Cancer Trialists' Collaborative Group): Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: Meta-analysis of individual patient data for 8,135 women in 22 randomised trials. Lancet 383:2127-2135, 2014
6. Huang O, Wang L, Shen K, et al: Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis: Analysis of 2,269 Chinese breast cancer patients treated with extended radical mastectomy. Breast Cancer Res Treat 107:379-387, 2008
7. Chen RC, Lin NU, Golshan M, et al: Internal mammary nodes in breast cancer: diagnosis and implications for patient management: A systematic review. J Clin Oncol 26:4981-4989, 2008
8. Hennequin C, Bossard N, Servagi-Vernat S, et al: Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy. Int J Radiat Oncol Biol Phys 86:860-866, 2013
9. Thorsen LB, Thomsen MS, Berg M, et al: Danish Breast Cancer Cooperative Group Radiotherapy committee: CT-planned internal mammary node radiotherapy in the DBCG-IMN study: benefit versus potentially harmful effects. Acta Oncol 53:1027-1034, 2014
10. Poortmans PM, Collette S, Kirkove C, et al: EORTC Radiation Oncology and Breast Cancer Groups: Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med 373:317-327, 2015
11. Whelan TJ, Olivotto IA, Parulekar WR, et al: MA.20 Study Investigators: Regional nodal irradiation in early-stage breast cancer. N Engl J Med 373:307-316, 2015
12. Musat E, Poortmans P, Van den Bogaert W, et al: Quality assurance in breast cancer: EORTC experiences in the phase III trial on irradiation of the internal mammary nodes. Eur J Cancer 43:718-724, 2007
13. Overgaard M, Christensen JJ: Postoperative radiotherapy in DBCG during 30 years: Techniques, indications and clinical radiobiological experience. Acta Oncol 47:639-653, 2008
14. Højris I, Overgaard M, Christensen JJ, et al: Radiotherapy Committee of the Danish Breast Cancer Cooperative Group: Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: Analysis of DBCG 82b and 82c randomised trials. Lancet 354:1425-1430, 1999
15. McGale P, Darby SC, Hall P, et al: Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother Oncol 100:167-175, 2011
16. Danish Breast Cancer Cooperative Group: DBCG: Danish Breast Cancer Cooperative Group. www.dbcg.dk
17. Møller S, Jensen MB, Ejlertsen B, et al: Danish Breast Cancer Cooperative Group: The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG): Its 30-years experience and future promise. Acta Oncol 47:506-524, 2008
18. Thorsen LB, Thomsen MS, Overgaard M, et al: Danish Breast Cancer Cooperative Group Radiotherapy Committee: Quality assurance of conventional non-CT-based internal mammary lymph node irradiation in a prospective Danish Breast Cancer Cooperative Group trial: The DBCG-IMN study. Acta Oncol 52:1526-1534, 2013
19. Ejlertsen B, Jensen MB, Rank F, et al: Danish Breast Cancer Cooperative Group: Population-based study of peritumoral lymphovascular invasion and outcome among patients with operable breast cancer. J Natl Cancer Inst 101:729-735, 2009
20. Chang JS, Park W, Kim YB, et al: Long-term survival outcomes following internal mammary node irradiation in stage II-III breast cancer: results of a large retrospective study with 12-year follow-up. Int J Radiat Oncol Biol Phys 86:867-872, 2013
21. Courdi A, Chamorey E, Ferrero JM, et al: Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients. Radiother Oncol 108:259-265, 2013
22. Olson RA, Woods R, Speers C, et al: Does the intent to irradiate the internal mammary nodes impact survival in women with breast cancer? A population-based analysis in British Columbia. Int J Radiat Oncol Biol Phys 83:e35-e41, 2012
23. Darby SC, McGale P, Taylor CW, et al: Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: Prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 6:557-565, 2005
24. Darby SC, Ewertz M, McGale P, et al: Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 368:987-998, 2013
25. Shapiro CL, Hardenbergh PH, Gelman R, et al: Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients. J Clin Oncol 16:3493-3501, 1998
26. Hooning MJ, Botma A, Aleman BM, et al: Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst 99:365-375, 2007
27. Tramm T, Kyndi M, Myhre S, et al: Relationship between the prognostic and predictive value of the intrinsic subtypes and a validated gene profile predictive of loco-regional control and benefit from post-mastectomy radiotherapy in patients with high-risk breast cancer. Acta Oncol 53:1337-1346, 2014
28. Mannino M, Yarnold JR: Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: Can radiotherapy ever be safely withheld? Radiother Oncol 90:14-22, 2009
29. Peto R, Davies C, Godwin J, et al: Early Breast Cancer Trialists'Collaborative Group: Comparisons between different polychemotherapy regimens for early breast cancer: Meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet 379:432-444, 2012
30. Grantzau T, Overgaard J: Risk of second non-breast cancer after radiotherapy for breast cancer: A systematic review and meta-analysis of 762,468 patients. Radiother Oncol 114:56-65, 2015
31. Korreman SS, Pedersen AN, Aarup LR, et al: Reduction of cardiac and pulmonary complication probabilities after breathing adapted radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys 65:1375-1380, 2006